The NIH-funded Polygenic Risk Methods in Diverse Populations (PRIMED) Consortium is developing and evaluating methods to improve the use of polygenic risk scores (PRS) to predict disease and health outcomes in diverse ancestry populations. 

For Researchers

Learn more about PRIMED Consortium research and ways to get involved.

For Consortium Members

Visit your customized dashboard to view consortium information.

"Output from a DNA Sequencer" / National Genome Research Institute
Improving disease prediction in diverse populations

The UW will serve as the Coordinating Center for NIH's new new Polygenic Risk Score Diversity Consortium.  NIH will fund consortium work through grants totaling $38 million over five years.


Read more
Styalized image of a DNA strand.
Recent publications
Chou, Alisha, et al. Association of prostate-specific antigen levels with prostate cancer risk in a multiethnic population: Stability over time and comparison with polygenic risk score. Cancer Epidemiology, Biomarkers & Prevention.
Jee, Yon Ho, et al. Polygenic Risk Scores for Prediction of Breast Cancer in Korean women. International Journal of Epidemiology.

See more